Trials / Conditions / Relapsed and Refractory Multiple Myeloma (RRMM)
Relapsed and Refractory Multiple Myeloma (RRMM)
3 registered clinical trials studyying Relapsed and Refractory Multiple Myeloma (RRMM) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | SL4903 CAR-T Therapy for Relapsed/Refractory Multiple Myeloma NCT07234721 | Institute of Hematology & Blood Diseases Hospital, China | EARLY_Phase 1 |
| Active Not Recruiting | Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory NCT06479954 | Pfizer | — |
| Completed | Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma NCT05673967 | Regeneron Pharmaceuticals | — |